BenevolentAI is a bioinformatics startup company that develops and applies artificial intelligence and machine learning technology. It has developed Judgement Augmented Cognition System, an AI technology that enables the analysis of scientific information. The system supplies researchers and scientists with analytical tools in the exploration of human health and bioscience applications.
The company also works on biomedical research in women's health issues, rare human diseases, veterinary medicine, cosmeceuticals, nutraceuticals, agricultural technology and other fields of industry.
Ken Mulvany, Brent Gutekunst, Ivan Griffin and Michael Brennan founded Stratified Medicine in November 13, 2013 in London, United Kingdom. The company changed its name to BenevolentAI in Sepetember 2016. It has offices in Cambridge, Belgium and New York.
Currently, no events have been added to this timeline yet.
Be the first one to add some.
BenevolentAI Limited: Private Company Information - Bloomberg
BenevolentAI: using artificial intelligence to speed up drug discovery - Pharmaceutical Technology
This AI unicorn is disrupting the pharma industry in a big way
Documentaries, videos and podcasts
Can a Machine Brain Cure Disease?
4 October 2017
- CompanyA company, abbreviated 'co.', is a legal entity made up of an association of people, be they natural, legal, or a mixture of both, for carrying on a commercial or industrial enterprise.
- BioinformaticsInterdisciplinary field that applies computational techniques to solve biological problems on the molecular level.
- StartupA startup company is an entrepreneurial venture in the initial stage of its operations. Startups are typically young businesses aiming to grow quickly and meet a marketplace need by developing or offering an innovative product, process or service.